Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
This bill amends the Public Health Service Act to require group and individual health plans to cover prostate cancer screening (PSA) without cost-sharing for men age 40 and older who are defined as high-risk. High-risk includes African-American men and men with a family history (defined by first‑degree relatives with prostate cancer, related cancers, or risk-related genetic alterations).
Progressives stress disparity reduction; conservatives stress federal overreach.
Relative to its intended legislative type, this bill clearly identifies a public-health problem and uses a direct statutory amendment to impose a coverage requirement on group and individual health plans.
This bill amends the Public Health Service Act to require group and individual health plans to cover prostate cancer screening (PSA) without cost-sharing for men age 40 and older who are defined as high-risk.
High-risk includes African-American men and men with a family history (defined by first‑degree relatives with prostate cancer, related cancers, or risk-related genetic alterations).
The bill also includes a clause about treating current USPSTF breast cancer screening recommendations as “most current” other than those from around November 2009.
Technically modest, health-focused change with some bipartisan appeal but faces insurer resistance, clinical guideline debate, and higher Senate hurdles.
Relative to its intended legislative type, this bill clearly identifies a public-health problem and uses a direct statutory amendment to impose a coverage requirement on group and individual health plans. It integrates into an existing statutory framework and sets an effective date, but leaves important operational, fiscal, and accountability details unspecified.
Progressives stress disparity reduction; conservatives stress federal overreach.
These are examples from the analysis, not a ranked list of the most-affected groups.
Progressives stress disparity reduction; conservatives stress federal overreach.
Likely views the bill favorably as a targeted, equity-focused expansion of preventive care that removes financial barriers for high-risk men.
Sees it as a pragmatic step to reduce racial disparities and increase early detection for men with family histories, while noting PSA screening debates.
Approves of targeted preventive access but is cautious about overriding evidence bodies and fiscal effects.
Appreciates focus on high-risk groups, but wants safeguards: monitoring, cost estimates, and alignment with future evidence.
Likely skeptical of the federal mandate requiring no-cost PSA screening, viewing it as federal overreach and a strain on insurers.
Raises concerns about scientific justification, overdiagnosis, and added costs passed to consumers.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technically modest, health-focused change with some bipartisan appeal but faces insurer resistance, clinical guideline debate, and higher Senate hurdles.
The bill has not accumulated any surfaced votes yet.
Progressives stress disparity reduction; conservatives stress federal overreach.
Technically modest, health-focused change with some bipartisan appeal but faces insurer resistance, clinical guideline debate, and higher S…
Relative to its intended legislative type, this bill clearly identifies a public-health problem and uses a direct statutory amendment to impose a coverage requirement on group and individual health plans. It integrates…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.